Literature DB >> 16013969

Molecular methods of hepatitis C genotyping.

Karen Weck1.   

Abstract

Hepatitis C virus is an RNA virus that is associated with chronic infection in the majority of people infected. Chronic infection with hepatitis C virus is the cause of significant morbidity and mortality worldwide and is associated with a large spectrum of liver disease including cirrhosis and hepatocellular carcinoma. End-stage liver disease due to chronic hepatitis C virus infection is currently the leading indication for liver transplantation in the USA. Hepatitis C virus genotyping of viral isolates circulating in the blood during chronic infection has become an important part of hepatitis C virus monitoring in chronically infected patients, and is useful as a prognostic indicator and to direct duration of therapy. This review will summarize information on hepatitis C genotyping, describe the limitations of current commercially available methods, give information on more recently developed methods, and provide a look to the future in terms of where advances in hepatitis C virus genotyping assays need to be made.

Entities:  

Mesh:

Year:  2005        PMID: 16013969     DOI: 10.1586/14737159.5.4.507

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  18 in total

1.  Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.

Authors:  Suwanna Noppornpanth; Erwin Sablon; Kathy De Nys; Xuan Lien Truong; Jan Brouwer; Marianne Van Brussel; Saskia L Smits; Yong Poovorawan; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

2.  Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region.

Authors:  Sueli M Nakatani; Carlos A Santos; Irina N Riediger; Marco A Krieger; Cesar A B Duarte; Marco A Lacerda; Alexander W Biondo; Flair J Carrilho; Flair J Carilho; Suzane K Ono-Nita
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

3.  Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity.

Authors:  Malihe Naderi; Atefeh Saeedi; Abdolvahab Moradi; Mishar Kleshadi; Mohammad Reza Zolfaghari; Ali Gorji; Amir Ghaemi
Journal:  Virol Sin       Date:  2013-05-25       Impact factor: 4.327

4.  Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.

Authors:  Jannick Verbeeck; Mark J Stanley; Jen Shieh; Linda Celis; Els Huyck; Elke Wollants; Judy Morimoto; Alice Farrior; Erwin Sablon; Margaret Jankowski-Hennig; Carl Schaper; Pamela Johnson; Marc Van Ranst; Marianne Van Brussel
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

Review 5.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

6.  Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories.

Authors:  R S Ross; S Viazov; S S Kpakiwa; M Roggendorf
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.

Authors:  Dimitry Gryadunov; Florence Nicot; Martine Dubois; Vladimir Mikhailovich; Alexander Zasedatelev; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  The phylogenetic analysis of hepatitis C virus isolates obtained from two Iranian carriers revealed evidence for a new subtype of HCV genotype 3.

Authors:  Safieh Amini; Malek-Hossein Ahmadi Pour; Kayhan Azadmanesh
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

9.  Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region.

Authors:  Koji Hara; Maria M Rivera; Christopher Koh; Sasan Sakiani; Jay H Hoofnagle; Theo Heller
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

10.  Evidence for a complex mosaic genome pattern in a full-length hepatitis C virus sequence.

Authors:  R S Ross; J Verbeeck; S Viazov; P Lemey; M Van Ranst; M Roggendorf
Journal:  Evol Bioinform Online       Date:  2008-10-30       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.